Volgen
Bastian Höchst
Bastian Höchst
Technische Universität München, Institute of Molecular Immunology
Geverifieerd e-mailadres voor tum.de - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+ CD25+ Foxp3+ T cells
B Hoechst, LA Ormandy, M Ballmaier, F Lehner, C Krüger, MP Manns, ...
Gastroenterology 135 (1), 234-243, 2008
9632008
Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
B Hoechst, T Voigtlaender, L Ormandy, J Gamrekelashvili, F Zhao, ...
Hepatology 50 (3), 799-807, 2009
6962009
Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells
B Hoechst, J Gamrekelashvili, MP Manns, TF Greten, F Korangy
Blood, The Journal of the American Society of Hematology 117 (24), 6532-6541, 2011
2712011
Functional classification of memory CD8+ T cells by CX3CR1 expression
JP Böttcher, M Beyer, F Meissner, Z Abdullah, J Sander, B Höchst, ...
Nature communications 6 (1), 8306, 2015
2642015
S100A9 a new marker for monocytic human myeloid‐derived suppressor cells
F Zhao, B Hoechst, A Duffy, J Gamrekelashvili, S Fioravanti, MP Manns, ...
Immunology 136 (2), 176-183, 2012
2392012
Kupffer cell-derived Tnf triggers cholangiocellular tumorigenesis through JNK due to chronic mitochondrial dysfunction and ROS
D Yuan, S Huang, E Berger, L Liu, N Gross, F Heinzmann, M Ringelhan, ...
Cancer cell 31 (6), 771-789. e6, 2017
1792017
Regulatory myeloid cells paralyze T cells through cell–cell transfer of the metabolite methylglyoxal
T Baumann, A Dunkel, C Schmid, S Schmitt, M Hiltensperger, K Lohr, ...
Nature immunology 21 (5), 555-566, 2020
1772020
Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCC
TF Greten, LA Ormandy, A Fikuart, B Höchst, S Henschen, M Hörning, ...
Journal of immunotherapy 33 (2), 211-218, 2010
1672010
Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion
B Höchst, FA Schildberg, P Sauerborn, YA Gäbel, H Gevensleben, ...
Journal of hepatology 59 (3), 528-535, 2013
1392013
Pancreatic premalignant lesions secrete tissue inhibitor of metalloproteinases-1, which activates hepatic stellate cells via CD63 signaling to create a premetastatic niche in …
B Grünwald, V Harant, S Schaten, M Frühschütz, R Spallek, B Höchst, ...
Gastroenterology 151 (5), 1011-1024. e7, 2016
1042016
Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity
B Knier, M Hiltensperger, C Sie, L Aly, G Lepennetier, T Engleitner, ...
Nature immunology 19 (12), 1341-1351, 2018
982018
Liver-primed memory T cells generated under noninflammatory conditions provide anti-infectious immunity
JP Böttcher, O Schanz, D Wohlleber, Z Abdullah, S Debey-Pascher, ...
Cell reports 3 (3), 779-795, 2013
902013
Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responses
F Zhao, B Hoechst, J Gamrekelashvili, LA Ormandy, T Voigtländer, ...
The Journal of Immunology 188 (12), 6055-6062, 2012
722012
Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance toward circulating carcinoembryonic antigen in mice
B Höchst, FA Schildberg, J Böttcher, C Metzger, S Huss, A Türler, ...
Hepatology 56 (5), 1924-1933, 2012
702012
Differential induction of Ly6G and Ly6C positive myeloid derived suppressor cells in chronic kidney and liver inflammation and fibrosis
B Höchst, J Mikulec, T Baccega, C Metzger, M Welz, J Peusquens, ...
PloS one 10 (3), e0119662, 2015
592015
Immune responses in hepatocellular carcinoma
F Korangy, B Höchst, MP Manns, TF Greten
Digestive diseases 28 (1), 150-154, 2010
572010
The induction of human myeloid derived suppressor cells through hepatic stellate cells is dose-dependently inhibited by the tyrosine kinase inhibitors nilotinib, dasatinib and …
A Heine, J Schilling, B Grünwald, A Krüger, H Gevensleben, SAE Held, ...
Cancer Immunology, Immunotherapy 65, 273-282, 2016
452016
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses
F Bayerl, P Meiser, S Donakonda, A Hirschberger, SB Lacher, AM Pedde, ...
Immunity 56 (6), 1341-1358. e11, 2023
332023
Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression
H Kalkavan, P Sharma, S Kasper, I Helfrich, AA Pandyra, A Gassa, ...
Nature Communications 8 (1), 14447, 2017
312017
Immunotherapy of hepatocellular carcinoma
F Korangy, B Höchst, MP Manns, TF Greten
Expert Review of Gastroenterology & Hepatology 4 (3), 345-353, 2010
312010
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20